The Science and Hope of Brain Cancer with Dr. Robert Thorne, Denali Therapeutics
About this episode
This episode features a deep conversation about brain cancer treatment and personal stories of loss with Dr. Robert Thorne.
In this powerful episode (#35) of BioTalk Unzipped , recorded live at the AAPS NBC conference in Boston, Gregory Austin engages in a deep conversation with a leading Neuroscientist, Dr. Robert Thorne, Denali Fellow at Denali Therapeutics, for an intimate and scientific deep dive into the evolving world of brain cancer treatment and CNS drug delivery. Both Gregory and Dr. Thorne share personal stories of losing family members to brain metastases, weaving in the emotional 'why' behind their professional paths. Dr. Thorne highlights the complexities of the blood-brain barrier, the heterogeneity of brain metastases, and cutting-edge delivery technologies—including focused ultrasound and molecular engineering approaches. The conversation also touches on pediatric brain tumors like diffuse midline glioma (DIPG), emerging research in lysosomal storage diseases, and the collaborative spirit driving innovation in neuroscience today. This is more than a technical discussion—it’s a human story about grief, hope, and the relentless pursuit of better outcomes for patients with brain diseases. 00:00 Preview & Intro 01:10 Robert Thorne’s Reflections on the AAPS NBC conference 03:14 The…
More episodes of BioTalk Unzipped
- Active Machine Learning for Drug Discovery & Nanomedicine with Dr. Daniel Reker
- Why Haven’t We Cured Cancer Yet? | Dr. Bob Liu Explains
- The Intersection of Biotech, Patent Law, and AI with Dr. Kate Neville, IP Attorney
- Long-acting Cell-Based Gene Therapy, Fabry Disease and Beyond with Glafabra CEO, Dr. Chris Hopkins
- Fail Fast, Learn Faster: Drug Development in Rare Disease with Dr. Binodh DeSilva
- Unlocking Antibody Development with AI with Dr. Pin-Kuang Lai
Explore listener stats, chart rankings, contacts and more on the BioTalk Unzipped podcast page.